Bromide

Bromide

SCHEMBL9293238

Br.O=C(CBr)C1CN2CCC1C2

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 known ✓ P08172 5/20 0.37
▸ CHRM3 known ✓ P20309 2/20 0.37
▸ CHRM1 P11229 4/20 0.37
▸ CHRM4 P08173 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL9293836 0.91 ALDH1A1 (0.41) CHRM2CHRM1CHRM4CHRM3ALDH1A1
SCHEMBL9523751 0.79 CHRM2 (0.41) CHRM2CHRM1CHRM4CHRM3ALDH1A1
Hydrochloric Acid SCHEMBL8935473 0.78 PEPD (0.43) CHRM2CHRM1CHRM4CHRM3ALDH1A1
Bromide SCHEMBL9298859 0.76 CHRM2 (0.41) CHRM2CHRM1CHRM4CHRM3ALDH1A1
Bromide SCHEMBL2424119 0.76 CHRM2 (0.41) CHRM2CHRM1CHRM4CHRM3ALDH1A1
SCHEMBL7913837 0.75 CHRM1 (0.45) CHRM2CHRM1CHRM4CHRM3ALDH1A1
SCHEMBL8935481 0.75 CHRM2 (0.36) CHRM2CHRM1CHRM4CHRM3ALDH1A1
SCHEMBL4339192 0.74 CHRM2 (0.42) CHRM2CHRM1CHRM4CHRM3ALDH1A1
SCHEMBL7493133 0.74 CHRM2 (0.42) CHRM2CHRM1CHRM4CHRM3ALDH1A1
SCHEMBL4762996 0.74 CHRM2 (0.42) CHRM2CHRM1CHRM4CHRM3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5324724-A Azabicyclic compounds; Alzheimer's disease treatment BEECHAM GROUP P.L.C. (GB) 1994-06-28 — — US disclosed
EP-0594605-A1 1-AZABICYCLIC COMPOUNDS, PROCESSES AND PHARMACEUTICAL COMPOSITONS CONTAINING THEM Beecham Group p.l.c. (GB) 1994-05-04 — — EP disclosed
US-5166357-A Nitrogen heterocylic compounds used in treatment of dementia in mammals BEECHAM GROUP P.L.C. (GB) 1992-11-24 — — US disclosed
WO-1991013885-A1 1-AZABICYCLIC COMPOUNDS, PROCESSES AND PHARMACEUTICAL COMPOSITONS CONTAINING THEM BEECHAM GROUP PLC (GB) 1991-09-19 — — WO disclosed
EP-0366304-A2 Heterocyclic derivatives, process for their preparation and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1990-05-02 — — EP disclosed
Send feedback